Stellar Infinity Company Ltd. - Net Worth and Insider Trading

Stellar Infinity Company Ltd. Net Worth

The estimated net worth of Stellar Infinity Company Ltd. is at least $63.6 Billion dollars as of 2024-06-23. Stellar Infinity Company Ltd. is the 2101 Beneficial owner of Hansoh Pharmaceutical Group Co Ltd and owns about 3,900,000,000 shares of Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) stock worth over $63.6 Billion. Details can be seen in Stellar Infinity Company Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stellar Infinity Company Ltd. has not made any transactions after 2020-04-29 and currently still holds the listed stock(s).

Transaction Summary of Stellar Infinity Company Ltd.

Stellar Infinity Company Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stellar Infinity Company Ltd. owns 1 companies in total, including Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) .

Click here to see the complete history of Stellar Infinity Company Ltd.’s form 4 insider trades.

Insider Ownership Summary of Stellar Infinity Company Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:03692	Hansoh Pharmaceutical Group Co Ltd	2020-04-29	2101 Beneficial owner

Stellar Infinity Company Ltd. Latest Holdings Summary

Stellar Infinity Company Ltd. currently owns a total of 1 stock. Stellar Infinity Company Ltd. owns 3,900,000,000 shares of Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) as of April 29, 2020, with a value of $63.6 Billion.

Latest Holdings of Stellar Infinity Company Ltd.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:03692	Hansoh Pharmaceutical Group Co Ltd	2020-04-29	3,900,000,000	16.32	63,648,000,000

Holding Weightings of Stellar Infinity Company Ltd.

Stellar Infinity Company Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Stellar Infinity Company Ltd. has made a total of 1 transactions in Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Hansoh Pharmaceutical Group Co Ltd is the sale of 0 shares on April 29, 2020, which brought Stellar Infinity Company Ltd. around $0.

Insider Trading History of Stellar Infinity Company Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stellar Infinity Company Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stellar Infinity Company Ltd. Ownership Network

Ownership Network List of Stellar Infinity Company Ltd.

No Data

Ownership Network Relation of Stellar Infinity Company Ltd.

Stellar Infinity Company Ltd. Owned Company Details

What does Hansoh Pharmaceutical Group Co Ltd do?

Who are the key executives at Hansoh Pharmaceutical Group Co Ltd?

Stellar Infinity Company Ltd. is the 2101 Beneficial owner of Hansoh Pharmaceutical Group Co Ltd. Other key executives at Hansoh Pharmaceutical Group Co Ltd include 2101 Beneficial owner Sun Yuan , 2307 Founder of a discretionary trust who can infl Cen Junda , and 2301 Trustee Cantrust (Far East) Limited .

Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) Insider Trades Summary

Over the past 18 months, Stellar Infinity Company Ltd. made no insider transaction in Hansoh Pharmaceutical Group Co Ltd (HKSE:03692). Other recent insider transactions involving Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) include a net sale of 0 shares made by Sun Yuan , a net sale of 0 shares made by Cantrust (Far East) Limited , and a net sale of 0 shares made by JQC Holding Limited .

In summary, during the past 3 months, insiders sold 0 shares of Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Hansoh Pharmaceutical Group Co Ltd (HKSE:03692)'s detailed insider trading history can be found in Insider Trading Tracker table.

Hansoh Pharmaceutical Group Co Ltd Insider Transactions

No Available Data

Stellar Infinity Company Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Stellar Infinity Company Ltd.. Currently GuruFocus does not have mailing address information for Stellar Infinity Company Ltd..

Discussions on Stellar Infinity Company Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.